IL2 and ovarian neoplasm: The increased levels of IL-2 and IFN-γ as well as the CD3+ T cell proportion in the antibody-secreting CAR-T-cell group suggested that the secreted forms of antibodies increased the immune response of MSLN CAR-T cells against ovarian tumor xenografts (Figure 5H).